Level Four Advisory Services’s Fortress Biotech FBIO Stock Holding History

Level Four Advisory Services’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,333	Closed	-$124K	–	651
2021 Q1	$124K	Hold	2,333	–	–	0.01%	618
2020 Q4	$111K	Buy	2,333 +133	+6%	+$5.76K	0.01%	580
2020 Q3	$133K	Hold	2,200	–	–	0.01%	527
2020 Q2	$89K	Hold	2,200	–	–	0.01%	558
2020 Q1	$62K	Buy	2,200 +133	+6%	+$4.41K	0.01%	475
2019 Q4	$797K	Hold	2,067	–	–	0.03%	309
2019 Q3	$44K	Buy	+2,067	New	+$48.6K	﹤0.01%	500

Other funds holding FBIO

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

SAM

Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return

CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Level Four Advisory Services's FBIO Position: Q2 2021 in Review

Level Four Advisory Services sold out of Fortress Biotech (FBIO) in Q2 2021, closing a stake of 2,333 shares — an estimated $124K sold.

Level Four Advisory Services first reported a position in FBIO in Q3 2019 and held it in 7 quarters. The position peaked at $797K in Q4 2019. 84 funds tracked by Wall St. Rank hold FBIO as of Q2 2021.

Level Four Advisory Services reported no remaining Fortress Biotech position as of Q2 2021 after selling out during the quarter.
Level Four Advisory Services sold 2,333 Fortress Biotech shares in Q2 2021, an estimated $124K.
Level Four Advisory Services first reported a position in Fortress Biotech in Q3 2019 and held it in 7 quarters.
Level Four Advisory Services's Fortress Biotech position peaked at $797K in Q4 2019.
84 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2021.

Based on Level Four Advisory Services's 13F filing for Q2 2021, filed 9 Aug 2021.